Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60


British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary.

Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Lanyon P, Luqmani R, Mallen C, Mason JC, Matteson EL, Merkel PA, Mollan S, Neill L, Sullivan EO, Sandovici M, Schmidt WA, Watts R, Whitlock M, Yacyshyn E, Ytterberg S, Dasgupta B.

Rheumatology (Oxford). 2020 Jan 23. pii: kez664. doi: 10.1093/rheumatology/kez664. [Epub ahead of print] No abstract available.


British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.

Mackie SL, Dejaco C, Appenzeller S, Camellino D, Duftner C, Gonzalez-Chiappe S, Mahr A, Mukhtyar C, Reynolds G, de Souza AWS, Brouwer E, Bukhari M, Buttgereit F, Byrne D, Cid MC, Cimmino M, Direskeneli H, Gilbert K, Kermani TA, Khan A, Lanyon P, Luqmani R, Mallen C, Mason JC, Matteson EL, Merkel PA, Mollan S, Neill L, Sullivan EO, Sandovici M, Schmidt WA, Watts R, Whitlock M, Yacyshyn E, Ytterberg S, Dasgupta B.

Rheumatology (Oxford). 2020 Jan 23. pii: kez672. doi: 10.1093/rheumatology/kez672. [Epub ahead of print] No abstract available.


Rheumatoid arthritis morning stiffness is associated with synovial fibrin and neutrophils.

Orange DE, Blachere NE, DiCarlo EF, Mirza S, Pannellini T, Jiang CS, Frank MO, Parveen S, Figgie MP, Gravallese EM, Bykerk VP, Orbai AM, Mackie SL, Goodman SM.

Arthritis Rheumatol. 2019 Oct 15. doi: 10.1002/art.41141. [Epub ahead of print]


Characteristics of patients with giant cell arteritis who experience visual symptoms.

Chean CS, Prior JA, Helliwell T, Belcher J, Mackie SL, Hider SL, Liddle J, Mallen CD.

Rheumatol Int. 2019 Oct;39(10):1789-1796. doi: 10.1007/s00296-019-04422-5. Epub 2019 Aug 22.


Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Mortimer I, Bissell LA, Hensor EMA, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Emery P, Morgan AW, Andrews J.

Rheumatology (Oxford). 2019 Sep 1;58(9):1684-1686. doi: 10.1093/rheumatology/kez114. No abstract available.


Cardiovascular risk factors associated with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Study.

Yates M, Luben R, Hayat S, Mackie SL, Watts RA, Khaw KT, Wareham NJ, MacGregor AJ.

Rheumatology (Oxford). 2020 Feb 1;59(2):319-323. doi: 10.1093/rheumatology/kez289.


2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.

Ehlers L, Askling J, Bijlsma HW, Cid MC, Cutolo M, Dasgupta B, Dejaco C, Dixon WG, Feltelius N, Finckh A, Gilbert K, Mackie SL, Mahr A, Matteson EL, Neill L, Salvarani C, Schmidt WA, Strangfeld A, van Vollenhoven RF, Buttgereit F.

Ann Rheum Dis. 2019 Sep;78(9):1160-1166. doi: 10.1136/annrheumdis-2018-214755. Epub 2019 Mar 21.


A probability score to aid the diagnosis of suspected giant cell arteritis.

Laskou F, Coath F, Mackie SL, Banerjee S, Aung T, Dasgupta B.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):104-108. Epub 2019 Feb 15.


Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.

Owen CE, Yates M, Twohig H, Muller S, Neill LM, Harrison E, Shea B, Simon LS, Hill CL, Mackie SL.

J Rheumatol. 2019 Oct;46(10):1360-1364. doi: 10.3899/jrheum.181050. Epub 2019 Feb 1.


Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.


Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group.

Cheah JTL, Black RJ, Robson JC, Navarro-Millán IY, Young SR, Richards P, Beard S, Simon LS, Goodman SM, Mackie SL, Hill CL.

J Rheumatol. 2019 Sep;46(9):1179-1182. doi: 10.3899/jrheum.181082. Epub 2019 Jan 15.


Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1316. doi: 10.1093/rheumatology/key411. No abstract available.


Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1123-1125. doi: 10.1093/rheumatology/key326. No abstract available.


Comparative effectiveness of 18F-FDG PET-CT and contrast-enhanced CT in the diagnosis of suspected large-vessel vasculitis.

Vaidyanathan S, Chattopadhyay A, Mackie SL, Scarsbrook AF.

Br J Radiol. 2018 Sep;91(1089):20180247. doi: 10.1259/bjr.20180247. Epub 2018 Jul 5.


Comorbidity in polymyalgia rheumatica.

Chatzigeorgiou C, Mackie SL.

Reumatismo. 2018 Mar 27;70(1):35-43. doi: 10.4081/reumatismo.2018.1039. Review.


Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis.

Lai LYH, Harris E, West RM, Mackie SL.

RMD Open. 2018 Feb 28;4(1):e000521. doi: 10.1136/rmdopen-2017-000521. eCollection 2018.


Preliminary concurrent validity of the Fitbit-Zip and ActiGraph activity monitors for measuring steps in people with polymyalgia rheumatica.

Chandrasekar A, Hensor EMA, Mackie SL, Backhouse MR, Harris E.

Gait Posture. 2018 Mar;61:339-345. doi: 10.1016/j.gaitpost.2018.01.035. Epub 2018 Jan 31.


Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.

Sajawal S, Mackie SL, Hillmen P, McGonagle D.

BMJ Case Rep. 2017 Nov 8;2017. pii: bcr-2017-221065. doi: 10.1136/bcr-2017-221065.


A Survey of Glucocorticoid Adverse Effects and Benefits in Rheumatic Diseases: The Patient Perspective.

Black RJ, Goodman SM, Ruediger C, Lester S, Mackie SL, Hill CL.

J Clin Rheumatol. 2017 Dec;23(8):416-420. doi: 10.1097/RHU.0000000000000585.


What is the impact of giant cell arteritis on patients' lives? A UK qualitative study.

Liddle J, Bartlam R, Mallen CD, Mackie SL, Prior JA, Helliwell T, Richardson JC.

BMJ Open. 2017 Aug 23;7(8):e017073. doi: 10.1136/bmjopen-2017-017073.


The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.

Mackie SL, Twohig H, Neill LM, Harrison E, Shea B, Black RJ, Kermani TA, Merkel PA, Mallen CD, Buttgereit F, Mukhtyar C, Simon LS, Hill CL; OMERACT PMR Working Group.

J Rheumatol. 2017 Oct;44(10):1515-1521. doi: 10.3899/jrheum.161109. Epub 2017 Aug 1.


Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.

Prior JA, Ranjbar H, Belcher J, Mackie SL, Helliwell T, Liddle J, Mallen CD.

BMC Med. 2017 Jun 28;15(1):120. doi: 10.1186/s12916-017-0871-z. Review.


A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group.

Black RJ, Robson JC, Goodman SM, Hoon E, Lai LYH, Simon LS, Harrison E, Neill L, Richards P, Nelsen LM, Nebesky JM, Mackie SL, Hill CL.

J Rheumatol. 2017 Nov;44(11):1754-1758. doi: 10.3899/jrheum.161083. Epub 2017 Apr 1.


A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.


Achieving consensus on minimum data items (including core outcome domains) for a longitudinal observational cohort study in rheumatoid arthritis.

Nikiphorou E, Mackie SL, Kirwan J, Boers M, Isaacs J, Morgan AW, Young A.

Rheumatology (Oxford). 2017 Apr 1;56(4):550-555. doi: 10.1093/rheumatology/kew416.


Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.

Halls S, Sinnathurai P, Hewlett S, Mackie SL, March L, Bartlett SJ, Bingham CO 3rd, Alten R, Campbell I, Hill CL, Holt RJ, Hughes R, Kirwan JR, Leong AL, Leung YY, Lyddiatt A, Neill L, Orbai AM.

J Rheumatol. 2017 Dec;44(12):1904-1910. doi: 10.3899/jrheum.161073. Epub 2016 Dec 15.


Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.

Bissell LA, Hensor EM, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Andrews J, Emery P, Morgan AW.

Rheumatology (Oxford). 2016 Dec;55(12):2181-2190. Epub 2016 Sep 16.


Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis.

Hernández-Rodríguez J, Murgia G, Villar I, Campo E, Mackie SL, Chakrabarty A, Hensor EM, Morgan AW, Font C, Prieto-González S, Espígol-Frigolé G, Grau JM, Cid MC.

Medicine (Baltimore). 2016 Feb;95(8):e2368. doi: 10.1097/MD.0000000000002368.


Response to: 'A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?' by Yang et al.

Mackie SL, McGonagle DG.

Ann Rheum Dis. 2016 Apr;75(4):e17. doi: 10.1136/annrheumdis-2015-208962. Epub 2016 Jan 27. No abstract available.


Outcome Measures in Polymyalgia Rheumatica. A Systematic Review.

Duarte C, Ferreira RJ, Mackie SL, Kirwan JR, Pereira da Silva JA; OMERACT Polymyalgia Rheumatica Special Interest Group.

J Rheumatol. 2015 Dec;42(12):2503-11. doi: 10.3899/jrheum.150515. Epub 2015 Nov 15. Review.


Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.

Helliwell T, Brouwer E, Pease CT, Hughes R, Hill CL, Neill LM, Halls S, Simon LS, Mallen CD, Boers M, Kirwan JR, Mackie SL.

J Rheumatol. 2016 Jan;43(1):182-6. doi: 10.3899/jrheum.141179. Epub 2015 Nov 15. Review.


Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review.

Mackie SL, Koduri G, Hill CL, Wakefield RJ, Hutchings A, Loy C, Dasgupta B, Wyatt JC.

RMD Open. 2015 Aug 13;1(1):e000100. doi: 10.1136/rmdopen-2015-000100. eCollection 2015.


Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids.

Mackie SL, Pease CT, Fukuba E, Harris E, Emery P, Hodgson R, Freeston J, McGonagle D.

Ann Rheum Dis. 2015 Dec;74(12):2188-92. doi: 10.1136/annrheumdis-2015-207395. Epub 2015 Sep 16.


Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Mackie SL, Taylor JC, Haroon-Rashid L, Martin S, Dasgupta B, Gough A, Green M, Hordon L, Jarrett S, Pease CT, Barrett JH, Watts R, Morgan AW; UK GCA Consortium; UKRAG Consortium.

Arthritis Res Ther. 2015 Jul 30;17:195. doi: 10.1186/s13075-015-0692-4.


Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

Aydin SZ, Direskeneli H, Sreih A, Alibaz-Oner F, Gul A, Kamali S, Hatemi G, Kermani T, Mackie SL, Mahr A, Meara A, Milman N, Nugent H, Robson J, Tomasson G, Merkel PA.

J Rheumatol. 2015 Dec;42(12):2465-9. doi: 10.3899/jrheum.141144. Epub 2015 Jun 15. Review.


Curry-assisted diagnosis in the rheumatology clinic.

Donaldson SL, Cobine-Davies M, Morgan AW, Gough A, Mackie SL.

Oxf Med Case Reports. 2015 Jun 1;2015(6):297-9. doi: 10.1093/omcr/omv040. eCollection 2015 Jun.


"An impediment to living life": why and how should we measure stiffness in polymyalgia rheumatica?

Mackie SL, Hughes R, Walsh M, Day J, Newton M, Pease C, Kirwan J, Morris M.

PLoS One. 2015 May 8;10(5):e0126758. doi: 10.1371/journal.pone.0126758. eCollection 2015.


The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.

Harris E, Tiganescu A, Tubeuf S, Mackie SL.

Curr Rheumatol Rep. 2015 Jun;17(6):513. doi: 10.1007/s11926-015-0513-4. Review.


A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Carmona FD, Mackie SL, Martín JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castañeda S, Cid MC, Hernández-Rodríguez J, Prieto-González S, Solans R, Ramentol-Sintas M, González-Escribano MF, Ortiz-Fernández L, Morado IC, Narváez J, Miranda-Filloy JA; Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schönau V, Franke A, Palm Ø, Molberg Ø, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, González-Gay MA, Morgan AW, Martín J.

Am J Hum Genet. 2015 Apr 2;96(4):565-80. doi: 10.1016/j.ajhg.2015.02.009. Epub 2015 Mar 26.


HLA allele variation as a potential explanation for the geographical distribution of granulomatosis with polyangiitis.

Watts RA, MacGregor AJ, Mackie SL.

Rheumatology (Oxford). 2015 Feb;54(2):359-62. doi: 10.1093/rheumatology/keu321. Epub 2014 Aug 28. Review.


Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCA.

Mackie SL, Dasgupta B.

Nat Rev Rheumatol. 2014 May;10(5):264-5. doi: 10.1038/nrrheum.2014.38. Epub 2014 Mar 18. No abstract available.


Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewé RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2014 May;41(5):994-9. doi: 10.3899/jrheum.131309. Epub 2014 Mar 15.


Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.

Mackie SL, Arat S, da Silva J, Duarte C, Halliday S, Hughes R, Morris M, Pease CT, Sherman JW, Simon LS, Walsh M, Westhovens R, Zakout S, Kirwan JR.

J Rheumatol. 2014 Apr;41(4):819-23. doi: 10.3899/jrheum.131254. Epub 2014 Feb 1. Review.


Polymyalgia rheumatica.

Mackie SL, Mallen CD.

BMJ. 2013 Dec 3;347:f6937. doi: 10.1136/bmj.f6937. Review. No abstract available.


Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez Martín J, de Miguel E, Magro C, Raya E; UK GCA Consortium; Spanish GCA Consortium, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J.

Ann Rheum Dis. 2013 Nov;72(11):1882-1886. doi: 10.1136/annrheumdis-2013-203641. Epub 2013 Aug 14.


Polymyalgia rheumatica: pathogenesis and management.

Mackie SL.

Clin Med (Lond). 2013 Aug;13(4):398-400. doi: 10.7861/clinmedicine.13-4-398. Review. No abstract available.


Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips.

Mackie SL, Pease CT.

Postgrad Med J. 2013 May;89(1051):284-92. doi: 10.1136/postgradmedj-2012-131400. Epub 2013 Jan 25. Review.


The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis.

Higgins MJ, Mackie SL, Thalayasingam N, Bingham SJ, Hamilton J, Kelly CA.

Clin Rheumatol. 2013 Jun;32(6):863-7. doi: 10.1007/s10067-013-2174-x. Epub 2013 Jan 23.


Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis.

Mackie SL, Hensor EM, Morgan AW, Pease CT.

Ann Rheum Dis. 2014 Jan;73(1):143-8. doi: 10.1136/annrheumdis-2012-202145. Epub 2012 Dec 22. Review.


Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study.

Mackie SL, Taylor JC, Twigg S, Martin SG, Steer S, Worthington J, Barton A, Wilson AG, Hocking L, Young A, Emery P, Barrett JH, Morgan AW.

Ann Rheum Dis. 2012 Oct;71(10):1640-5. doi: 10.1136/annrheumdis-2011-201003. Epub 2012 Mar 22.


Supplemental Content

Loading ...
Support Center